UBS’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

UBS’s Portfolio VIRX Stock Details VIRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$5.32M	Buy
2014 Q2	$3.21M	Buy
2014 Q1	$1.72M	Buy
2013 Q4	$833K	Sell
2013 Q3	$1.07M	Buy
2013 Q2	$1.1M	Buy